Approval · Notice of Compliance 36770 · 2026
SILENOR: Notice of Compliance 36770
Issued January 22, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36770
- Date
- January 22, 2026
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
Medicinal ingredients
- DOXEPIN HCL 3 MG per TAB
- DOXEPIN HCL 6 MG per TAB